Effexor Buyers To Join 3rd Circ. Appeal Against Wyeth, Teva
By Aaron Vehling ( January 23, 2015, 7:10 PM EST) -- A class of direct purchasers of antidepressant Effexor XR on Friday notified a New Jersey federal judge that they plan a Third-Circuit appeal of his decision to dismiss their claim against Wyeth Inc. and Teva Pharmaceuticals USA Inc. over a no-authorized-generic deal for the drug, a week after a number of other Effexor buyers announced a similar intent to appeal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.